Skip to main content

Table 4 Outcomes at 6 and 12 months for the two cohorts, including mortality, hospitalizations, emergency department (ED) visits, prescription orders, and costs, with significant differences in bold

From: Reducing mortality in hip fracture patients using a perioperative approach and “Patient- Centered Medical Home” model: a prospective cohort study

  Medical home cases Controls p-values
Mortality    
   N, subjects per group 97 97 --
   N, Deaths at 6 months (%) 11 (11%) 25 (26%) <0.01
   N, Deaths at 12 months (%) 22 (23%) 29 (30%) 0.12
Healthcare utilization    
   N, matched subjects per group 97 97 --
   Hospitalizations per 100 patients at 6 months 12.4 13.4 0.84
   ED visits per 100 patients at 6 months 35.1 34.0 0.91
   Prescription orders per patient at 6 months 34.0 31.6 0.69
   Hospitalizations per 100 patients at 12 months 23.2 25.7 0.83
   ED visits per 100 patients at 12 months 69.6 54.3 0.42
   Prescription orders per patient at 12 months 56.5 40.2 0.16
Healthcare costs    
   N, matched subjects per group 15 15 --
   Mean pharmacy costs per patient-month (0–6 months) $100 $175 0.27
   Mean non-pharmacy costs per patient-month (0–6 months) $3,527 $3,572 0.95
   Mean total costs per patient-month (0–6 months) $3,627 $3,509 0.89
   Mean pharmacy costs per patient-month (0–12 months) $69 $141 0.20
   Mean non-pharmacy costs per patient-month (0–12 months) $1,212 $1,452 0.45
   Mean total costs per patient-month (0–12 months) $1,281 $1,496 0.52
Quality of life and function at 12 months    
   N, matched subjects per group 35 35 --
   Mean EQ-5D index* 0.76 0.73 0.49
   Mean EQ-5D QOL scale** 72 72 0.99
   Harris hip pain/Function score^ 73 64 0.04
  1. Sample sizes differ among outcomes because of availability of cost, questionnaire data, and questionnaire outcomes were assessed only at 12 months.
  2. *EQ-5D Index is on a scale of 0–1 with 1 = best.
  3. **EQ-5D QOL Scale is on a scale of 0–100 with 100 = best.
  4. ^Harris Hip pain/function score is on a scale of 0–91 with 91 = best.
  5. All costs have been normalized such that pharmacy costs (0–6 months) for the MH group = $100.